|The company creates value by proprietary knowledge-based technologies which include proteomic and various state-of-the-art molecular biology techniques exploiting the current scientific and aqusitions mostly from own research of molecular biology, biochemistry and genetics of the vitamin E-binding protein afamin.
R&D activities have been funded by national and international public research grants. The research achievements have been subject of 7 international granted patent applications.
Vitateq developed an ELISA kit for detection and quantifiction of afamin in biological fluids.
This ELISA kit is fully developed, is based upon proprietary monoclonal antibodies and has already been tested successfully for its accuracy and precision in several thousand human healthy and diseased groups.
|3D Structure Model of Afamin
(American Chemical Society, Copyright 2005)